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Abstract
Hormesis occurs when a low level stress elicits adaptive beneficial responses that protect against subsequent exposure to
severe stress. Recent findings suggest that mild oxidative and thermal stress can extend lifespan by hormetic mechanisms.
Here we show that the botanical pesticide plumbagin, while toxic to C. elegans nematodes at high doses, extends lifespan at
low doses. Because plumbagin is a naphthoquinone that can generate free radicals in vivo, we investigated whether it
extends lifespan by activating an adaptive cellular stress response pathway. The C. elegans cap‘n’collar (CNC) transcription
factor, SKN-1, mediates protective responses to oxidative stress. Genetic analysis showed that skn-1 activity is required for
lifespan extension by low-dose plumbagin in C. elegans. Further screening of a series of plumbagin analogs identified three
additional naphthoquinones that could induce SKN-1 targets in C. elegans. Naphthazarin showed skn-1dependent lifespan
extension, over an extended dose range compared to plumbagin, while the other naphthoquinones, oxoline and
menadione, had differing effects on C. elegans survival and failed to activate ARE reporter expression in cultured mammalian
cells. Our findings reveal the potential for low doses of naturally occurring naphthoquinones to extend lifespan by engaging
a specific adaptive cellular stress response pathway.
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Introduction
As organisms age, cellular proteins, lipids and nucleic acids
sustain damage that can lead to functional deficits in tissues and,
ultimately, death. The free radical theory of aging proposes that
aging results, at least in part, from damage to cellular components
by reactive oxygen species (ROS), such as nitroxides, hydrogen
peroxide and superoxide anion. Indeed, oxidative modification is a
major form of damage detected in aging tissues [1–3]. ROS occur
as byproducts of normal mitochondrial metabolism, but are also
produced by environmental sources, including some biological
toxins. Levels of oxidative damage correlate with relative age and
extent of functional decline, consistent with oxidative damage
acting as a contributing force driving tissue decline with age [4,5].
Aging-related diseases, such as Alzheimer’s disease and cancer,
have also been linked to oxidative damage [6,7]. Multiple lines of
evidence suggest that attenuating stressful insults or increasing
stress resistance can delay aging and functional decline in model
organisms and in human tissues [8–10]. Such data support the
concept that chemicals with prolongevity activity can be identified
by their ability to activate stress response pathways.
Stress hormesis occurs when toxic agents elicit beneficial effects
at low concentrations and is classically described by an inverted U-
shaped dose response curve [11]. Stress hormesis has been
observed for both thermal and oxidative stressors. Sublethal
thermal stress is protective against subsequent thermal stress in
yeast, worms, and flies [12–14]. In Caenorhabditis elegans, sublethal
thermal stress can extend adult lifespan, suggesting that thermal
stress responses overlap with prolongevity pathways in this
organism [13,15,16]. Chemical stress can induce heat shock
protein expression and thermotolerance in Saccharomyces cerevisiae
[17]. Cultured cells and whole organisms are protected from
oxidative stress by pretreatments with hyperbaric oxygen or low
levels of free-radical generators such as paraquat or juglone
[16,18]. In addition, mild oxidative stress from low concentrations
of juglone extended C. elegans lifespan, suggesting that oxidative
stress response pathways also overlap with prolongevity pathways
in C. elegans [19]. The close link between stress and aging suggests
that interventions harnessing hormetic mechanisms may extend
lifespan or delay age-associated functional decline. However,
challenges for developing hormetic mechanisms into anti-aging
therapies include the relatively small dose range providing
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studies are needed to determine the feasibility of modifying
hormetic agents to extend the beneficial dose range and minimize
toxicity.
Here, we report that hormetic chemicals can be modified to
optimize beneficial effects and minimize toxicity in C. elegans,a
model for studying aging in whole organisms. C. elegans is well-
suited to this problem due to the short lifespan, ease of genetic
manipulation and transparent anatomy. First, we examined
whether lifespan extension is common among biological toxins
with various chemical structures and mechanisms of action. In a
small screen of natural phytochemicals, we identified two ROS
generating compounds, plumbagin and juglone, which extended
lifespan at subtoxic doses. Mean lifespan extension by plumbagin
was dependent on SKN-1, a cap‘n’collar transcription factor that
promotes antioxidant gene expression in response to oxidative
stress [20]. We further screened a collection of six plumbagin
analogs, identifying three additional naphthoquinones that
activated expression of a skn-1 target. One of these could extend
lifespan over a larger range of doses than plumbagin, demon-
strating the utility of stress hormesis mechanisms as promising
prolongevity intervention. The other compounds had differing
effects on longevity, possibly reflecting structure-specific alterations
in stability and toxicity. This work highlights C. elegans as an
experimental approach for identifying lead compounds with the
potential to act on conserved targets.
Results
A screen for biological toxins with hormetic prolongevity
activity
To gain a better understanding about the ability of phytotoxins
to extend lifespan through stress hormesis mechanisms, we
conducted a small screen of 14 phytochemicals which was derived
from a larger collection of 30 phytochemicals used to identify
compounds activating stress response pathways in cultured cells
[21]. These compounds represented a diverse range of chemicals,
including lignins, lipids, alcohols and cyclic compounds, encom-
passing at least three modes of action, ROS generators,
antifeedants and neurotoxins (Table 1). For the C. elegans screen,
we examined survival of populations of roughly 40 sterile fem-
1(hc17) adults treated with each of the 14 phytochemicals [22].
First, each phytotoxin was tested for toxicity at 200 mM. Four
phytotoxins were toxic at this dose (plumbagin, visnagin, eugenol
and farnesol) and were retested at 100 mM (Table 1). At 100 mM,
toxicity was observed for plumbagin, visnagin and eugenol, while
farnesol had no effect. Plumbagin, visnagin and eugenol were
further tested at 60, 30 and 10 mM doses. At both 60 and 30 mM,
plumbagin demonstrated a prolongevity effect with treated
animals surviving longer than controls. A previous study reported
that 50 mM plumbagin was toxic to C. elegans [23]. This variation
in hormetic and toxic dose ranges for plumbagin may reflect
variability in culturing conditions between laboratories. We
further tested 300 mM doses for 10 phytotoxins that were not
toxic at 200 mM. Of these, juglone, piperine, veratrine and
asarone were toxic at 300 mM, although they had shown no
benefit or toxicity at 200 mM. We examined these at 100 mM and
found that juglone was beneficial and could extend lifespan at this
concentration. In an independent study, 40 mM juglone extended
C. elegans lifespan in axenic media [19].
The microbial environment can be a source of stress that
shortens C. elegans lifespan [24,25]. Therefore, all subsequent
experiments were conducted in the presence of 5-fluoro-29-
deoxyuridine (FUDR), a DNA synthesis inhibitor which is both
bacteriostatic and bacteriocidal [26,27]. In four trials with wild
type C. elegans, treatment with 25 mM plumbagin was associated
with an average increase in mean lifespan of 12+/22%
(p,0.0001, two-way ANOVA) (Fig. 1, Table S1). Treatment with
50 mM plumbagin was also associated with a significant increase of
mean lifespan in two of three trials. These doses of plumbagin did
not increase maximum lifespan. Plumbagin’s prolongevity effect
was lost at 100 mM and doses between 200–500 mM were toxic.
Based on this screen, we conclude that plumbagin and juglone
possessed hormetic activity that could extend lifespan in C. elegans.
Table 1. Screen for hormetic prolongevity activity in C. elegans.
Mechanism Compound Notes Relative survival; (mM dose)
300 200 100 60 30 10
ROS generators Plumbagin antiproliferative yellow pigment ,,. . <
Juglone herbicidal brown pigment , < .
Visnagin vasodilator ,,, , <
Neurotoxins Eugenol TRPV channel agonist ,,<<<
Piperine TRPV channel agonist , <<
Veratrine Na+ channel antagonist , <<
Anabasine Nicotinic agonist <<<
Domoic acid Neurotoxin <<
Antifeedants Farnesol Membrane disruptor Sesquiterpenoid , <
a-Asarone Phenylpropanoid , <<
Marmesin Coumarin <<
Precocene II Cytotoxin <<
Sesamin Lignin <<
Translation inhibitor L-canavanine Arginine analog <<
Empty cells, dose not tested; (,) shorter survival than untreated controls; (<) approximately equal survival to untreated controls; (.) longer survival than untreated
controls.
doi:10.1371/journal.pone.0021922.t001
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tested, although we cannot rule out the possibility that we failed to
test the appropriate doses for hormesis.
Low concentrations of plumbagin extend C. elegans
lifespan through stress-responsive transcription factors
To identify pathways activated by plumbagin, we performed
microarray analysis of C. elegans gene expression after a 2-day
treatment with 100 mM plumbagin. This dose is slightly greater
than that required for stress hormesis but is only weakly toxic to
adult C. elegans (0%, 211%, 216% in 3 trials, Table S1). We chose
this dose with the goal of maximizing the expression level of
plumbagin-responsive genes. GO analysis revealed that the
strongest effect of plumbagin was upregulated expression of
oxidoreductase activity, consistent with plumbagin’s action as an
oxidative stressor (Fig. 2A) [28,29]. Additionally, plumbagin
treatment was associated with repression of growth, development
and reproductive processes, indicating a shift from energy
expenditure to energy conservation and repair (Fig. 2B). Plumba-
gin treatment led to the upregulation of several genes for
glutathione-S-transferases, cytochrome P450 enzymes and small-
molecule dehydrogenases, as was previously observed for juglone
and hyperbaric oxygen in C. elegans [30,31].
CNC-family NF-E2 transcription factors direct antioxidant
enzyme expression as part of the Phase 2 stress response, an
important pathway for cellular oxidative stress resistance [32].
Plumbagin activates NF-E2 target genes in human neuroblastoma
cells [21]. Therefore, the C. elegans CNC transcription factor,
SKN-1, is one candidate for mediating the beneficial effects of
plumbagin. Our microarray analysis surveyed 14 of the top 15
upregulated skn-1 targets [33]. Plumbagin treatment increased
expression of 9 of these skn-1 targets by 2-fold or greater (Table 2).
A second candidate effector for plumbagin’s benefits is the stress-
responsive FoxO transcription factor, DAF-16. In C. elegans,
stresses such as growth factor withdrawal, starvation, oxidative and
heat stress, trigger DAF-16/FoxO nuclear translocation and
expression of target genes [14,34–37]. In C. elegans, lifespan
extension by stress hormesis from juglone required daf-16 activity
[19]. The activities of skn-1 and daf-16 are interdependent for
lifespan regulation [38]. Among 38 upregulated daf-16 target genes
[39] surveyed in our experiment, only two were upregulated with
100 mM plumbagin (Table 3). Plumbagin did not alter expression
of sod-3, a direct target of DAF-16 [35].
Next, we examined whether lifespan extension by low-dose
plumbagin required skn-1 and daf-16 activity. Consistent with a
role for skn-1,2 5mM plumbagin did not extend lifespan of skn-
1(zu135) animals in four independent trials (Fig. 3B). Additionally,
skn-1 RNAi abrogated lifespan extension from treatment with 10,
25 and 50 mM plumbagin (Table S2). Furthermore, skn-1 RNAi
enhanced toxicity of plumbagin at doses of 50 mM and above.
Thus, skn-1 activity was required both for the longevity benefits of
plumbagin, and for normal resistance to plumbagin toxicity.
We also examined the effects of plumbagin on lifespan in both
daf-16(mgDf50); daf-2(e1370) and daf-16(mgDf50) backgrounds
lacking daf-16 activity (Fig. 3C, D). Lifespan was extended by
plumbagin treatment in these daf-16-deficient backgrounds,
although the effect was significantly weaker and more variable
than in the wildtype background. Together, these results implicate
both skn-1 and daf-16 as mediators of lifespan extension by low-
doses of plumbagin.
A GFP reporter for a SKN-1 transcriptional target is a
dose-responsive biosensor of plumbagin exposure
Using GFP reporters, we examined whether activation of skn-1
or daf-16 by low-dose plumbagin could be monitored in vivo. C.
elegans strain CL2166 carries a GFP reporter expressed from the
gst-4 promoter [40]. The gst-4 promoter contains two predicted
SKN-1 binding sites and Pgst-4::GFP expression induced in
response to oxidative stress from hyperbaric oxygen and hydrogen
peroxide was skn-1-dependent [41]. Treatment with 25 mM
plumbagin induced expression of Pgst-4::GFP in the intestine,
with weaker expression in the head and body muscles (Fig. 4B).
We quantified Pgst-4::GFP fluorescence in the bodies of animals
treated for 48 hours with 0-150 mM plumbagin, encompassing a
range of beneficial and toxic doses. The increase in Pgst-4::GFP
was approximately linear between 0-50 mM plumbagin and
appeared to become saturated, but also variable, at higher
plumbagin doses (Fig. 4A, Table S2). In three trials, the beneficial
Figure 1. Low-dose plumbagin increases mean lifespan in C. elegans by stress hormesis. (A) Survival of wildtype adults treated with
DMSO vehicle, 25 or 250 mM plumbagin. Mean lifespan was extended by 25 mM plumbagin (n=137, p,0.0001) while the 250 mM dose was toxic and
shortened lifespan (n=144, p,0.0001). (B) Dose-response curve for mean survival relative to plumbagin concentration (mM). The plot shows an
inverted U-shaped curve characteristic of stress hormesis. Error bars indicate variation in two to four independent lifespan experiments per dose.
Individual trial data are presented in Table S1.
doi:10.1371/journal.pone.0021922.g001
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PLoS ONE | www.plosone.org 3 July 2011 | Volume 6 | Issue 7 | e21922Figure 2. Transcriptional effects of plumbagin under non-toxic conditions in C. elegans. (A,B) Results of GO analysis of molecular function
(A) and biological processes (B) for transcripts differently expressed in animals treated with plumbagin versus vehicle (DMSO). Results indicate
upregulation of genes involved in oxidative stress resistance functions (A) and biological functions related electron transport (B), possible related to
electron capture. Furthermore, reductions in growth and developmental processes were identified in plumbagin-treated animals, consistent with a
shift of resources to stress response.
doi:10.1371/journal.pone.0021922.g002
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increase in Pgst-4::GFP fluorescence over background (p,0.001,
T-test). 50 mM plumbagin induced a range of Pgst-4::GFP levels,
with whole worm fluorescence increased by 96%, 173%, and
241% compared to controls in three trials. We note that 50 mM
plumbagin increased lifespan in a subset of trials, suggesting that
this concentration may represent the upper end of the beneficial
dose range. Pgst-4::GFP induction by plumbagin was skn-1-
dependent. In animals treated with skn-1 RNAi, plumbagin failed
to induce Pgst-4::GFP expression in most tissues (Fig. 4B; Table 4).
The idea that there is an optimal window of skn-1 activity for
lifespan extension is consistent with data showing that moderate
over-expression of skn-1 extended lifespan while high-copy over-
expression of skn-1 was toxic [38].
In cultured mammalian neurons, plumbagin activated expres-
sion of target genes containing the antioxidant response element
(ARE) in an Nrf2-dependent manner [21]. Nrf2 activity is induced
in response to oxidative stress and plumbagin has reported ROS
generating activity [42]. We therefore examined whether plum-
bagin activation of ARE-containing targets could be altered by
treatment with glutathione, an antioxidant capable of scavenging
plumbagin-generated ROS. Indeed, ARE-reporter induction by
plumbagin was significantly diminished by cotreatment with
glutathione (Fig. 4C). These data support the hypothesis that
plumbagin activates Nrf2 target gene expression through alter-
ation of the cellular redox environment.
In two independent experiments with 20 animals each, 25 mM
plumbagin failed to increase nuclear localization of a DAF-
16::GFP reporter (Fig. 4D). Therefore, we utilized the Pgst-4::GFP
for a biosensor of stress hormesis in all subsequent experiments.
Analysis of plumbagin analogs for improved
benefit:toxicity profiles
Two problems for translating interventions based on stress
hormesis mechanisms are the limited dose range for beneficial
Table 2. Effect of plumbagin on expression of skn-1 targets.
Sequence ID Gene name skn-1 target * Plumbagin treatment
Fold-change P
K08F4.7 gst-4 ! 4.9 ,0.001
C32H11.4 ! 2.1 0.001
C32H11.12 dod-24 ! 2.0 0.006
ZK1058.6 nit-1 ! 2.5 ,0.001
Y45G12C.2 gst-10 ! 2.3 0.01
K10D11.1 dod-17 ! 2.7 ,0.001
C32H11.3 ! 1.9 0.01
Y102A11A.3 ! 21.1 0.89
T26C5.1 gst-13 ! 1.8 0.05
F56D5.3 ! 3.8 ,0.001
K10C2.3 ! 1.7 ,0.001
F23B2.12 pcp-2 ! 1.1 0.53
F55G11.2 ! 2.0 ,0.001
C35B1.5 ! 2.0 0.02
Average fold-change from 4 biological replicates comparing gene expression in
animals treated with 100 mM plumbagin vs DMSO vehicle control using C.
elegans 4x44K oligo microarrays (Agilent Technologies, USA).
*14 skn-1 targets (Oliveira et al. 2009).
doi:10.1371/journal.pone.0021922.t002
Table 3. Effect of plumbagin on expression of daf-2 pathway targets.
Sequence ID
‘
Gene name Plumbagin treatment Sequence ID
‘
Gene name Plumbagin treatment
Fold-change P Fold-change P
C55B7.4 acdh-1 21.2 0.39 F38E11.2 hsp-12.6 -1.2 0.24
C46F4.2 acs-17 1.0 0.64 T27E4.8 hsp-16.1 1.1 0.57
F32A5.5 aqp-1 1.2 0.02 Y46H3A.3 hsp-16.2 1.0 0.55
K11D2.2 asah-1 1.0 0.54 C02A12.4 lys-7 23.4 0.002
H22K11.1 asp-3 21.6 0.13 C17G10.5 lys-8 1.2 0.68
C50B8.2 bir-2 21.1 0.60 R03E9.1 mdl-1 21.6 0.15
Y54G11A.6 ctl-1 21.3 0.04 K11G9.6 mtl-1 2.2 0.01
Y54G11A.5 ctl-2 21.2 0.21 F49E11.9 scl-1 21.6 0.76
T10B9.1 cyp-13A4 21.2 0.06 F43D9.4 sip-1 1.0 0.47
B0213.15 cyp-34A9 21.3 0.23 C08A9.1 sod-3 1.0 0.14
K07C6.4 cyp-35B1 21.4 0.41 K12G11.3 sodh-1 1.4 0.003
K07E3.3.2 dao-3 21.0 0.68 K12G11.4 sodh-2 1.8 ,0.001
C24B9.9.1 dod-3 21.7 0.14 T07C4.4 spp-1 21.0 0.26
T20G5.7 dod-6 1.4 0.42 T22G5.7 spp-12 1.7 ,0.001
F10D2.9 fat-7 21.0 0.23 C06B3.4 stdh-1 1.2 0.33
C52E4.1 gcp-1 21.0 0.36 F11A5.12 stdh-2 1.2 ,0.001
C05E4.9 gei-7 1.2 0.48 F28D1.3 thn-1 21.1 0.25
R12A1.4 ges-1 21.2 0.97 AC3.7 ugt-1 1.0 0.17
T28B8.2 ins-18 21.5 0.87
‘ 37 daf-2 pathway targets (Murphy et al. 2003).
doi:10.1371/journal.pone.0021922.t003
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whether plumbagin analogs existed which could activate skn-1 and
extend C. elegans lifespan without significant toxicity at higher
doses. A group of six plumbagin analogs, consisting of 3
naphthoquinones and 3 tetralones, was screened for activation of
Pgst-4::GFP and effects on lifespan in C. elegans. Tetralones, which
lack the 4-ketone of plumbagin, did not activate Pgst-4::GFP
fluorescence (Table S3) and conferred no survival benefit at any
tested dose (Table S1). In addition, the tetralones were generally
non-toxic to C. elegans at concentrations up to 500 mM.
In contrast to the tetralones, all three naphthoquinones,
menadione, naphthazarin and oxoline, increased Pgst-4::GFP
expression, although not as strongly as plumbagin (Fig 5A, B;
Table S3). As with plumbagin, increases in Pgst-4::GFP
expression in worms treated with naphthazarin and oxoline
were abrogated by skn-1 RNAi (data not shown). Plumbagin, but
not menadione, was previously shown to induce the Nrf2-
mediated Phase 2 response in cultured mammalian cells [21].
We therefore compared activation of the Nrf2-dependent ARE
reporter by naphthazarin, oxoline and plumbagin in HepG2
cells. Both plumbagin and naphthazarin induced the ARE
reporter, while oxoline failed to activate the ARE reporter at up
to 100-fold higher concentrations (Fig. 5C). We also examined
survival of HepG2 cells in the presence of each naphthoquinone.
Plumbagin and naphthazarin had similar toxicity profiles, while
oxoline was approximately 100-fold less toxic than plumbagin
(Fig. 5D).
We considered the possibility that naphthoquinones extended
lifespan by protective effects against bacterial proliferation. The
classical approach for testing this possibility is to measure lifespan
in worms fed on a lawn of dead or growth-inhibited bacteria. As
mentioned, all lifespan assays were conducted in the presence of
FUDR, which is bacteriostatic and bacteriocidal. Consistently,
average lifespan was longer when using FUDR-containing
medium as compared to medium lacking FUDR (20.2 days vs
15.9 days, respectively; p,0.0001, Log-Rank). This eliminated the
possibility that plumbagin, naphthazarin and oxoline extended
lifespan by simply inhibiting bacterial growth. We further probed
Figure 3. Effect of plumbagin on adult lifespan of skn-1 and daf-16 mutants. (A–C) Mean adult lifespan on 25 mM plumbagin (filled columns)
compared to vehicle control (unfilled columns) was measured in 4 independently-conducted trials for (A) wildtype, (B) skn-1(zu135) and (C) daf-
16(mgDf50); daf-2(e1370) adults. Asterisks mark trails in which mean adult lifespan was extended by 25 mM plumbagin treatment with Log-Rank
probability . 0.01. Lifespan data for additional plumbagin doses is presented on Table S1. (D) Dose-response curve of daf-16(mgDf50) adult lifespan
at 0, 10, 25, 50 and 100 mM plumbagin. Asterisk indicates a positive effect of plumbagin on lifespan with Log-Rank probability . 0.01. Data for
lifespan trials is presented in Table S1.
doi:10.1371/journal.pone.0021922.g003
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heat-killed bacteria. However, these experiments were confounded
by the fact that naphthoquinone toxicity was significantly higher in
the presence of heat-killed bacteria (Table S4). There are several
explanations for this result. One is that bacteria were protective
against naphthoquinone toxicity which was necessary to unmask
the hormetic effects in C. elegans. Thus, growth on heat-killed
bacteria could have shifted the hormetic dose range to doses that
were much lower than those we tested. An alternative explanation
is that bacteria enzymatically converted the naphthoquinones into
products with hormetic activity in C. elegans. We did not further
investigate these possibilities.
Naphthazarin and oxoline extended C. elegans lifespan
through different mechanisms
We found that naphthazarin and oxoline, but not menadione,
could extend C. elegans lifespan. At doses between 100–500 mM,
naphthazarin treatment was associated with increased mean and
maximum lifespan (e.g., 200 mM, 13+/26% increase in mean
lifespan, P,0.0001 in each of three trials) (Fig. 6A; Table S1). For
oxoline, a 500 mM dose extended mean lifespan by 13–15% in 3 of
4 trials and increased maximum lifespan by at least 10% in all 4
trials. 1 mM oxoline was also associated with significant increases
in mean and maximum lifespan (Fig. 6B; Table S1). Comparison
of relative Pgst-4::GFP fluorescence and lifespan indicated that
Figure 4. Effect of low-dose plumbagin on DAF-16, SKN-1 and ARE transcriptional reporters in C. elegans and HepG2 cells. (A) Dose-
response curve for Pgst-4::GFP fluorescence versus plumbagin concentration. Levels of Pgst-4::GFP were determined for a minimum of 20 worms per
condition per trial by average background-subtracted values for whole worm fluorescence of treated animals normalized to controls; p,0.0001 (T-
test) in every trial at doses of 20 mM plumbagin and above. Each data point represents a single trial. Results for individual trials are shown in Table S2.
(B) Representative images of Pgst-4::GFP in wildtype day 1 adults treated for two days with 25 mM plumbagin under control conditions (left panel) or
with skn-1 RNAi (right panel). In control animals, 25 mM plumbagin was associated with increased Pgst-4::GFP in the intestine and muscles and skn-1
RNAi abrogated the increases in Pgst-4::GFP fluorescence levels. Bar, 0.2 mm. (C) ARE reporter activity in HepG2 cells treated with DMSO vehicle
control (open) or 4 mM plumbagin (shaded). Plumbagin activated ARE reporter beta-lactamase expression. Co-incubation with reduced glutathione
significantly reduced induction of the ARE reporter by plumbagin. Data are relative beta-lactamase activity + SEM. (D) Adult TH356 hermaphrodites
expressing a DAF-16::GFP translational fusion were treated as indicated and localization of DAF-16::GFP monitored as a measure of DAF-16 activation.
Thermal stress (37uC, 20 minutes) induced dramatic nuclear accumulation of DAF-16::GFP in intestinal nuclei. In contrast, DMSO vehicle and 25 mM
plumbagin treatments failed to induce nuclear DAF-16::GFP accumulation. Two independent experiments were performed with n=20 animals/
treatment. For DMSO and plumbagin, animals were transferred to treatments and DAF-16:GFP localization was scored after 3, 24 and 48 hours.
Shown are representative 48-hour treatments. Bar, 0.1 mm; all images were collected using identical exposure times.
doi:10.1371/journal.pone.0021922.g004
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were associated with 50–150% increased Pgst-4::GFP expression
(Table 5). However, Pgst-4::GFP expression was not strictly
correlated with lifespan extension, as menadione, which also
induced Pgst-4::GFP within this range, had no effect on lifespan at
low concentrations and was toxic at high concentrations (Fig. 6C).
This may reflect additional toxic effects of menadione in vivo.
Because beneficial doses of napthazarin and oxoline could
induce skn-1-dependent Pgst-4::GFP expression at levels similar to
those induced by beneficial doses of plumbagin, we tested
whether lifespan extension by oxoline and naphthazarin were also
skn-1 dependent. Animals treated with skn-1 RNAi lived shorter
on 200 mM naphthazarin than controls, with an average 10%
decrease in mean and maximum lifespan over 4 trials (Fig. 7A;
Table S2). The decrease was more severe in skn-1(zu135)
mutants, in which lifespan was only 55+/210% of controls in
four trials (Fig. 7C; Table S1). These results indicate that lifespan
extension by naphthazarin was dependent on skn-1, and that skn-
1 activity was protective against naphthazarin toxicity. In
contrast, skn-1 RNAi did not block lifespan extension by oxoline
in 3 of 4 trials (Fig. 7B; Table S2). Additionally, 500 mMo x o l i n e
increased mean lifespan by 12+/28% in skn-1(zu135) (Fig. 7C;
Table S1). The finding that oxoline influenced lifespan indepen-
dently of skn-1 is consistent with the finding that oxoline did not
induce the ARE reporter in HepG2 cells. In daf-16(mgDf50);daf-
2(e1370) animals, both 200 mM naphthazarin and 500 mM
oxoline increased mean lifespan by 11+/22%, indicating that
lifespan extension by both compounds was independent of daf-16
activity (Fig 7D; Table S1).
Discussion
Our findings and those of previous studies [43,44] suggest that
interventions activating stress response pathways can reduce
cellular damage, thereby slowing aging and increasing lifespan.
Phytochemicals that exert cytoprotective effects, such as curcumin
[45,46] and sulforaphane [47,48], do so by inducing the Phase 2
detoxification response via NF-E2 transcription factors. Here, we
characterized the ability of three naphthoquinones, plumbagin,
naphthazarin and oxoline, to extend C. elegans lifespan through
stress hormesis pathways linked to the antioxidant response. In our
study, lifespan extension by plumbagin and naphthazarin was
dependent on skn-1 activity. In the absence of skn-1 activity, the
hormetic benefits of plumbagin were lost. In C. elegans, lifespan
extension from stress hormesis by thermal stress and juglone-
induced oxidative stress also require daf-16 [19,49]. Lifespan
extension by plumbagin was weaker and more variable in daf-16
mutants than in wildtype animals, suggesting that daf-16 is a
component of the hormetic pathway induced by plumbagin.
However, we did not detect daf-16 target gene induction or DAF-
16::GFP nuclear localization by hormetic doses of plumbagin.
Reduced insulin/IGF-1-like signaling (IIS) from the DAF-2/IIS
receptor increases nuclear accumulation of SKN-1 and activates a
subset of skn-1 dependent genes (including gst-4) independently of
DAF-16 [38]. The interactions between daf-16 and skn-1
complicate efforts to tease apart their individual roles in this
pathway. For this reason, further study will be necessary to clearly
define the daf-16’s role in lifespan extension by low-dose
plumbagin.
One aim of this study was to identify derivatives of a hormetic
chemical that display broad beneficial dose ranges and lower
toxicity. Such properties would be necessary in order to consider
clinical translation of hormetic interventions. By comparing the
relative effects of plumbagin on longevity and Pgst-4::GFP
expression, we predicted that compounds which increased Pgst-
4::GFP expression by 50-150% above basal levels would also
extend lifespan. Plumbagin doses that activated expression above
this level were toxic, possibly due to excessive levels of oxidative
stress and cellular damage. We identified three naphthoquinones,
naphthazarin, oxoline and menadione, that could induce Pgst-
4::GFP. One of these, naphthazarin, behaved similarly to
plumbagin with a broader beneficial dose range, as desired.
Naphthazarin extended lifespan at doses which induced Pgst-
4::GFP expression to the same range as hormetic doses of
plumbagin. Overall, naphthazarin was less potent than plumbagin
in C. elegans.
Although menadione induced Pgst-4::GFP within the predicted
beneficial range, it failed to extend lifespan at any concentration
tested. One explanation is that menadione affects cells through
multiple mechanisms, which overlap partially with mechanisms for
plumbagin toxicity. Findings in Saccharomyces cerevisiae are consistent
with this idea. Low-dose pretreatment with either plumbagin or
menadione induced adaptive responses protective against plum-
bagin toxicity, while low-dose plumbagin failed to protect from
menadione toxicity [50]. These data are consistent with the idea
that menadione has additional toxic activities that may mask its
potential benefits in C. elegans.
Oxoline, the third plumbagin derivative we studied, extended C.
elegans lifespan through skn-1- and daf-16-independent mecha-
nisms. Oxoline weakly activated Pgst-4::GFP and failed to activate
ARE reporter expression in HepG2 cells. We found oxoline to be
non-toxic to C. elegans and mammalian cells within the tested dose
range. Oxoline belongs to the class of bacteriocidal quinolone
antibiotics that inhibit DNA topoisomerase activity. Oxoline has
been prescribed for treatment of urinary tract infections from
gram-negative bacteria and is used for antiviral therapy [51,52].
Based on this evidence, it is possible that oxoline affects C. elegans
lifespan through antimicrobial effects.
Table 4. Effect of skn-1 RNAi on Pgst-4::GFP induction by
plumbagin.
Expt.
Plumbagin
(mM) RNAi AMPI ‘
Std.
Dev. Ratio { P* n
1 0 L4440 8.2 2.0 22 30
skn-1 3.7 0.5 0.46 ,.001 30
25 L4440 12.9 2.2 1.57 ,.001 20
skn-1 4.3 0.6 0.52 ,.001 20
2 0 L4440 5.3 0.9 22 34
skn-1 2.7 0.4 0.52 ,.001 34
100 L4440 32.2 8.6 6.08 ,.001 32
skn-1 4.4 0.7 0.84 ,.001 36
3 0 L4440 5.8 0.9 22 33
skn-1 2.7 0.4 0.46 ,.001 33
100 L4440 23.0 5.1 3.94 ,.001 22
skn-1 4.8 1.2 0.82 ,.01 20
Animals (CL2166) were raised from embryo to adulthood on HT115 bacteria
containing either the L4440 RNAi vector or a plasmid inducing skn-1 RNAi.
Adults were treated for two days with plumbagin or DMSO vehicle control
before GFP visualization.
‘ AMPI represents the average whole worm background subtracted mean pixel
intensity for the treatment group.
{AMPI ratio for treatment relative to the L4440 vehicle (DMSO) control.
T-test compares the AMPI of each worm in the treatment group with those of
the control (0 mM plumbagin, L4440) in that experiment.
doi:10.1371/journal.pone.0021922.t004
Hormetic Lifespan Extension in C. elegans
PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e21922Although the oxidative stress response is molecularly conserved
between worms and mammals, we uncovered differences between
these systems that call for caution when attempting to extrapolate
effects of specific longevity interventions across species. For
instance, oxoline induced Pgst-4::GFP expression in C. elegans but
failed to induce an ARE reporter in mammalian cells. Moreover,
sulforaphane and plumbagin had different relative effects on
expression of ARE reporter and Pgst-4::GFP levels [21]. Numerous
differences between C. elegans nematodes and cultured mammalian
cells could affect the activities of specific compounds in each
system. First, compounds are likely to enter cultured cells more
easily than C. elegans adults, which are surrounded by an
impermeable cuticle. Second, intact C. elegans may possess a
distinct array of metabolizing enzymes from cultured cells which
could alter the production of bioactive metabolic intermediates.
Third, the systems differ in mechanisms for excreting compounds
from the cellular cytoplasm. Finally, the culture conditions for
nematodes and cells are different and expose the compounds to
significantly different environments.
We propose that C. elegans provides a facile approach to
identifying families of compounds that can activate targets with
conserved anti-aging or stress response functions. However,
individual compounds within such families may have distinct
activities reflecting differences in uptake, metabolism and environ-
Figure 5. Effects of naphthazarin, oxoline and menadione on skn-1 and Nrf2 targets in C. elegans and HepG2 cells. (A) Structures of
plumbagin, naphthazarin, oxoline and menadione. (B) Induction of Pgst-4::GFP by naphthazarin, oxoline, and menadione. Data are results from
independent experiments measuring whole worm Pgst-4::GFP fluorescence compared to vehicle-treated controls (Table S3). For comparison, the
average level of Pgst-4::GFP fluorescence in plumbagin-treated animals is shown on the same plot (diamonds, data shown on Fig. 4A). Shaded
diamonds, naphthazarin, n$30, p,0.0001 for 100 mM and above; triangles, oxoline, n$16, p,0.0001 for 500 mM and above; crosses, menadione,
n$18, p,0.0001 for 100 mM and above. (C) Plumbagin (diamonds) and naphthazarin (shaded diamonds) activated ARE reporter expression (beta-
lactamase) in HepG2 cells. Toxicity at higher concentrations of plumbagin and naphthazarin resulted in decreased reporter gene expression. Oxoline
(triangles) failed to induce expression of ARE driven beta-lactamase. The ARE reporter cell line HepG2 was exposed to the indicated concentrations of
plumbagin, naphthazarin or oxoline and ARE-driven beta-lactamase activity was assessed 24 hrs after exposure. Data are mean beta-lactamase
activity 6 SEM (n=324). (D) HepG2 cells were treated with plumbagin (diamonds), naphthazarin (shaded diamonds) or oxoline (triangles) at
indicated concentrations. Cell viability was assessed 24 hrs after exposure. Results are the mean from 324 experiments +/2 SEM.
doi:10.1371/journal.pone.0021922.g005
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compared to identify those with maximal effectiveness in a
particular experimental system or therapeutic context. In this light,
our findings positively demonstrate that stress hormesis mechanisms
can be accessed for longevity benefits in a whole organism, such as
C. elegans, and that structural analogs of hormetic compounds may
have improved toxicity profiles. However, care must be taken when
extrapolating findings about specific compounds between experi-
mental systems.
Materials and Methods
Chemicals
The following chemicals were obtained commercially, as
indicated: plumbagin (#P7262), naphthazarin (#388513), mena-
dione (Fluka #67900), visnagin (#254932), eugenol (#35995),
farnesol (#F203), alpha-asarone (#231282), piperine (#P49007),
L-canavanine (#C1625), domoic acid (#D6152), precocene II
(#194913), sesamin (sesamol, #S8518), juglone (#H47003), 5-
hydroxy-1-tetralone (#219975) and 5,8- dimethoxy-1-tetralone
(#569658) were obtained from Sigma-Aldrich Co., St. Louis, MO;
veratrine (#219834) was from MP Biomedicals, Solon, OH;
anabasine (#L18484) was from Alfa Aesar, Ward Hill, MA and
marmesan (#CDL 0080-0004) was from Chemical Diversity, San
Diego, CA. Oxoline was obtained from Wako Chemicals,
Richmond, VA (#328-67371). 7-hydroxy-1-tetralone was ob-
tained from Milestone PharmaTech, New Brunswick, NJ (#2A-
0017). For each, chemical characterization was performed to
confirm the correct chemical structure and, for agents that proved
less than 98% pure, recrystallization and purification procedures
were performed to obtain high chemical purity. Chemicals were
stored at 220uC as 100 mM stock solutions in DMSO. To
prepare C. elegans media for experimental treatments, chemicals
were added from stock solutions to molten NGM agar and then
poured into 3.5-cm culture dishes for use, with the exception of the
screen for hormetic chemicals.
C. elegans strains and growth conditions
C. elegans strains Bristol N2 (wild-type), CL2166 (N2; dvIs19
(Pgst-4::gfp; rol-6)), TJ356 (N2; zIs356 (daf-16::gfp; rol-6)), EU31
(skn-1(zu135)/DnT1), and CY312 (daf-16(mgDf50);daf-2(e1370))
were utilized in this work. Strains were grown and maintained
at 15uC or room temperature (22 to 24uC) on Nematode Growth
Media (NGM) containing 2.1% agar with E. coli strain OP50 as a
food source [53], except as indicated for RNAi experiments. Age-
synchronized populations were obtained by collecting the eggs laid
by fertile adults over 5 to 7 hours and allowing them to develop to
the young adult stage before transfer to treatment plates.
Table 5. Effects of plumbagin, naphthazarin and oxoline on Pgst-4::GFP and lifespan in wildtype C. elegans.
Dose (mM) Plumbagin Naphthazarin Oxoline
Ratio Pgst-4::GFP* Ratio lifespan
{ Ratio Pgst-4::GFP* Ratio lifespan
{ Ratio Pgst-4::GFP* Ratio lifespan
{
1 0.94 1.01
2.5 1.03
5 0.97 1.03
7.5 1.00
10 1.06 1.08
15 1.23
20 1.29
25 1.57 1.12
35 1.79
50 2.70 1.07 1.01 1.02 1.02
100 4.00 0.91 1.43 1.10 1.17 1.04
150 3.97 0.77
200 0.16 1.63 1.12
250 0.12
300 0.14
400 0.10
500 0.14 1.63 1.15 1.54 1.11
1000 2.07 1.12
*Ratio of Pgst-4::GFP fluorescence in animals treated with indicated dose versus vehicle. Data for individual trials is presented in Table S3.
{Ratio of adult lifespan in animals treated with indicated dose versus vehicle. Data for individual trials is presented in Table S1.
doi:10.1371/journal.pone.0021922.t005
Figure 6. Effects of naphthazarin, oxoline, and menadione on C. elegans survival. (A–C) Dose-response relationship of relative C. elegans
survival with respect to naphthoquinone concentration. Chemical structures for each compound are shown on each plot. (A) Naphthazarin increased
C. elegans lifespan at higher doses than plumbagin. Data represent one trial at 50 mM (n=67, p=0.2), and three trials each at 100 mM( n $93,
p,0.0001 in 2 of 3 trials), 200 mM( n $96, p,0.0001 in 3 of 3 trials), and 500 mM( n $66, p,0.0001 in 2 of 3 trials). (B) Oxoline treatment extended
mean lifespan at doses of 500 mM( n $95, p,0.0001 in 3 of 4 trials) and 1 mM (n$61, p,0.0001 in 2 of 2 trials). (C) Menadione treatment shortened C.
elegans lifespan and did not provide a significant lifespan benefit at any tested dose (13 trials at various concentrations with n$59 per condition,
p,0.0001 in all trials at 100 mM and above).
doi:10.1371/journal.pone.0021922.g006
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The stable Nrf2/ARE reporter cell line, ARE-bla HepG2, was
purchased from Invitrogen (Carlsbad, CA, USA) and maintained
in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 10%
dialyzed fetal bovine serum (FBS), 2 mM glutamine, 0.1 mM
nonessential amino acids, 25 mM HEPES, 1% penicillin/
streptomycin, and 5 mg/ml of blasticidin (Invitrogen) at 37uCi n
a humidified 5% CO2 atmosphere. Blasticidin was removed from
the media during experimental treatments. For cell viability and
ARE reporter assays, ARE-bla HepG2 cells were plated in 96-well
plates and allowed to adhere overnight. Cell viability was assessed
24 hours after incubation with the indicated concentration of
plumbagin, naphthazarin and oxoline by Celltiter 96H AQUE-
OUS One Solution reagent (Promega, Madison, WI, USA). Nrf2-
transactivation was measured by beta-lactamase activity according
to the manufacturer’s instructions (Invitrogen). All experiments
were performed in triplicate.
Screen for hormetic prolongevity chemicals
For the initial screen, compounds were suspended to 100 mM
in either water or EtOH. 20 mL of each stock solution, diluted in
water to 150 mL immediately prior to use, was dropped onto the
Figure 7. Requirement for skn-1 in lifespan extension by naphthazarin. (A) skn-1 RNAi abrogated lifespan extension by 200 mM
naphthazarin. Filled squares, L4440 treated with DMSO vehicle control (n=80); open squares, skn-1 RNAi treated with DMSO vehicle control (n=125);
filled triangles, L4440 treated with 200 mM naphthazarin (n=88, p,0.0001); open triangles, skn-1 RNAi treated with 200 mM naphthazarin (n=127,
p,0.0001). (B) 500 mM oxoline was associated with similar increases in lifespan for both L4440 and skn-1 RNAi treated groups. Filled squares, L4440
treated with DMSO control (n=117); open squares, skn-1 RNAi treated with DMSO vehicle control (n=131); filled circles, L4440 treated with 500 mM
oxoline (n=106, p,0.0001); open circles, skn-1 RNAi treated with 500 mM oxoline (n=124, p,0.0001). (C) Lifespan of skn-1(zu135) adults was
shortened by 200 mM naphthazarin (triangles, n=110, p,0.0001) relative to DMSO vehicle control (squares, n=123), but lengthened by 500 mM
oxoline (circles, n=117, p,0.0001). (D) Mean lifespan of daf-16(mgDf50); daf-2(e1370) adults was extended by 200 mM naphthazarin (triangles,
n=116, p,0.0001) and 500 mM oxoline (circles, n=121, p,0.0001), relative to DMSO vehicle treated controls (squares, n=80).
doi:10.1371/journal.pone.0021922.g007
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bacterial food. Plates were incubated at room temperature for
2 hours to allow compounds to diffuse into the media to a final
concentration of 200 mM. Approximately 40 sterile fem-1(hc17)
adults, raised at 25uC, were suspended in water and dropped onto
the surface of test plates. Survival was scored daily for the first
week, then at 1–3 day intervals until all animals were dead.
Survival assays were terminated as soon as an outcome became
apparent relative to paired control populations treated with vehicle
alone. Chemicals that were toxic at 200 mM were tested at
100 mM. If the compound was toxic at 100 mM, it was further
tested at 60 mM, 30 mM and 10 mM. Compounds that were not
toxic at 200 mM were tested at 300 mM, and, if toxic, further
tested at 100 mM for possible beneficial effects. Vehicle controls
(water or ethanol) were included for all concentrations tested.
Lifespan analyses
In all lifespan assays, worms were grown on NGM agar until day 1
of adulthood, the first day following the L4-adult molt. Young adults
were transferred to fresh medium supplemented with indicated
compounds or 0.2% DMSO as a vehicle control. For most
treatments, the final concentration of the DMSO vehicle was
,0.2%. Lifespan assays were performed at room temperature (22–
23uC)and survival was scored every 2–4 days as the ability to move in
response to touch with a platinum wire. 200 mMF U D Rw a su s e di n
lifespan assays to prevent progeny production, except for experiments
with fem-1(hc17) hermaphrodites, which are sterile and do not
produce progeny [22,54]. FUDR is also bacteriocidal and bacterio-
static. Maximum lifespan was calculated by the mean lifespan of the
oldest 10% cohort in each experiment. Log-Rank P-values within
experiments were calculated using the Survival/Reliability function
in JMP 5.0.1.2 (SAS, USA). Significance probability P-values over
multiple experiments with the same conditions were calculated with
the GLM Procedure in SAS 9.2 (SAS, USA), with treatment and
experiment number as the two independent factors for two-way
ANOVA, and days of life as the dependent variable.
Microarray Analysis
Approximately 1,000 age-synchronized young adults were
treated for two days with either 100 mM plumbagin or DMSO
as a vehicle control and then washed three times in M9 and flash
frozen with dry ice. RNA was isolated with the Absolutely RNA
Miniprep Kit (Agilent Technologies, USA). RNA concentration
and quality was assessed using an Agilent Bioanalyzer 2100
(Agilent Technologies, USA). Microarray hybridizations were
performed with the C. elegans 4x44K Oligo Microarray (Agilent
Technologies, USA). Raw microarray hybridization intensity data
from four separate experiments were log-transformed and
normalized to generate z-scores and subsequent z-ratios [55].
RNA interference
RNA interference (RNAi) was induced by providing a food
source of HT115 bacteria expressing double-stranded RNA
corresponding to the targeted gene [56]. The RNAi medium
was NGM agar supplemented with 100 mg/mL ampicillin and
1 mM isopropyl b-D-thiogalactoside (IPTG) to induce bacterial
expression of the dsRNA trigger. Young adult animals (Po) were
placed onto RNAi plates for several hours to lay eggs and then
removed. Larvae developed to young adulthood on RNAi plates
and were then transferred to fresh RNAi plates supplemented with
test compounds or vehicle (DMSO). In this way, worms continued
feeding on dsRNA-expressing bacteria throughout the experiment.
Analysis of Pgst-4::GFP expression
Young CL2166 adults were transferred onto NGM agar
supplemented with test compounds or vehicle (DMSO). After
two days at room temperature (22–24uC), animals were mounted
on 2% agarose pads and immobilized with 20 mM levamisole.
Using a Nikon E900 microscope (Nikon Corporation, Japan), GFP
fluorescence was visualized with a mercury illumination source at
1006 magnification (10X objective, 10X ocular magnification).
Images were captured using Openlab software, v. 5.5.0 (Improvi-
sion Inc., USA) controlling a Hamamatsu Orca CCD camera
(Hamamatsu Photonics, Japan). Image processing was performed
using Adobe Photoshop CS3 (Adobe Systems Inc., USA). Levels of
Pgst-4::GFP were measured as average mean pixel intensity
(AMPI) over the whole worm using ImageJ software (Rasband,
W.S., U.S. National Institutes of Health, Bethesda, MD, http://
rsb.info.nih.gov/ij/). AMPI values were normalized by subtracting
the background intensity of the slide as measured by the minimum
pixel intensity in each image. Statistical significance was judged
using a two-tailed student’s t-test in Excel (v.12.2.4, Microsoft,
USA).
Supporting Information
Table S1 Lifespan assays were conducted as described in
Methods. Control lifespan varied by experiment, and individual
experiments can be identified by control mean lifespan; (+)
treatment; (2) DMSO vehicle control. * Mean lifespan of the 90
th
percentile. ‘ Log-Rank Probability.
(DOC)
Table S2 { Animals were grown from embryos on feeding RNAi
vector control bacterial strain L4440 or RNAi bacteria expressing
skn-1 dsRNA. Day 0 adults were transferred to treatment plates
with 200 mM FUdR to prevent progeny production; (+) treatment;
(2) DMSO vehicle control. * Mean lifespan of the 90
th percentile.
‘ Log-Rank Probability.
(DOC)
Table S3 CL2166 animals were grown to adulthood and treated
for two days as indicated. (+) Treatment; (-) DMSO vehicle
control. * AMPI represents the average whole worm background-
subtracted mean pixel intensity for the treatment group. { Ratio
given is the AMPI for the treatment group relative to the DMSO
control. ‘ T-test.
(DOC)
Table S4 # P, plumbagin; O, Oxoline; N, naphthazarin. ‘ (+)
Bacteria killed at 65uC for 1 hour; (2) Live bacteria spread onto
plates; both (+) and (2) plates contained FUDR to prevent
progeny production and control bacterial growth.
(DOC)
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